Marsh & McLennan Companies, Inc. (NYSE:MRSH – Get Free Report) has been given an average rating of “Hold” by the eighteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $200.1875.
MRSH has been the topic of a number of research analyst reports. Morgan Stanley dropped their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a research report on Monday, April 6th. Wells Fargo & Company cut their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a report on Thursday, April 9th. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target on the stock in a report on Wednesday, May 6th. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Finally, Bank of America cut their price target on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a report on Tuesday, April 14th.
Read Our Latest Stock Report on MRSH
Marsh & McLennan Companies Stock Down 0.3%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. On average, equities research analysts forecast that Marsh & McLennan Companies will post 10.38 EPS for the current year.
Insider Activity at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by company insiders.
Institutional Trading of Marsh & McLennan Companies
Institutional investors have recently modified their holdings of the company. State Street Corp acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $4,057,682,000. Capital International Investors acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $3,482,557,000. Capital World Investors acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $3,140,284,000. Wellington Management Group LLP acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $2,967,927,000. Finally, Price T Rowe Associates Inc. MD acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $1,710,101,000. 87.99% of the stock is currently owned by institutional investors.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
